Dijous, núm. 535 [PDF]
CITADELLE (535)
Vor § 535
ABSTRACT 535
Steinway Lines 535
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
Supplement 535